{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:51:42Z","timestamp":1793832702627,"version":"4.6.1"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Thyroid-associated ophthalmopathy (TAO) is an inflammatory orbital disease associated with autoimmune thyroid disorders. Owing to the ambiguous nature of the pathogenesis, contemporary pharmacological treatment strategies predominantly involve the use of glucocorticoids and immunosuppressants. However, the adverse effects associated with these agents in clinical practice necessitate further investigation into the disease\u2019s pathogenesis and the identification of novel therapeutic targets and pharmacological interventions. Recent studies suggest that ferroptosis, a novel form of regulated cell death, may play a role in TAO pathogenesis. This review aims to explore the involvement of ferroptosis in TAO and evaluate its potential as a therapeutic target. Key topics include the epidemiology, clinical manifestations, and pathophysiology of TAO, along with the molecular mechanisms of ferroptosis. Evidence supporting ferroptosis in TAO and the therapeutic implications of targeting this pathway are also discussed, alongside challenges and future directions in this emerging research area.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1475923","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T05:10:17Z","timestamp":1733461817000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Thyroid-associated ophthalmopathy and ferroptosis: a review of pathological mechanisms and therapeutic strategies"],"prefix":"10.3389","volume":"15","author":[{"given":"Chao","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.648732","article-title":"Mechanisms that underly T cell immunity in Graves' Orbitopathy","volume":"12","author":"Fang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02470-8","article-title":"Long-term outcome of Graves' orbitopathy following treatment with sirolimus","author":"Comi","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2020.1776331","article-title":"Clinical management and therapeutic strategies for the thyroid-associated ophthalmopathy: current and future perspectives","volume":"45","author":"Mishra","year":"2020","journal-title":"Curr Eye Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.615993","article-title":"Epidemiology, natural history, risk factors, and prevention of Graves' Orbitopathy","volume":"11","author":"Bartalena","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.952954","article-title":"Research progress on the pathogenesis of Graves' ophthalmopathy: Based on immunity, noncoding RNA and exosomes","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1186\/s12967-023-04664-9","article-title":"Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance","volume":"21","author":"D'Aprile","year":"2023","journal-title":"J Transl Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-24-0122","article-title":"Prediction models of intravenous glucocorticoids therapy response in thyroid eye disease","volume":"13","author":"Zhang","year":"2024","journal-title":"Eur Thyroid J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.893600","article-title":"Therapy with intravenous methylprednisolone pulses is associated with loss of bone microarchitecture in trabecular bone score -assessment among patients with moderate-to-severe Graves' Orbitopathy: A pilot study","volume":"13","author":"Rymuza","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578468","article-title":"Nicotine is an immunosuppressant: implications for women's health and disease","volume":"397","author":"White","year":"2024","journal-title":"J Neuroimmunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9210572","article-title":"Selenium supplementation may decrease thyroid peroxidase antibody titer via reducing oxidative stress in euthyroid patients with autoimmune thyroiditis","volume":"2020","author":"Tian","year":"2020","journal-title":"Int J Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000494837","article-title":"A 2018 European thyroid association survey on the use of selenium supplementation in Graves' Hyperthyroidism and Graves' Orbitopathy","volume":"8","author":"Negro","year":"2019","journal-title":"Eur Thyroid J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.13899","article-title":"Thyroid eye disease: Redefining its management-A review","volume":"49","author":"Jain","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/cells12060918","article-title":"Molecular mechanisms in autoimmune thyroid disease","volume":"16","author":"Vargas-Uricoechea","year":"2023","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2013.07.009","article-title":"How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis","volume":"47","author":"Morshed","year":"2013","journal-title":"J Autoimmun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.beem.2011.10.002","article-title":"Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy","volume":"26","author":"Smith","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2528046","article-title":"Cytokines in thyroid-associated ophthalmopathy","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Immunol Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57060621","article-title":"TGF-\u03b2 Physiology as a novel therapeutic target regarding autoimmune thyroid diseases: where do we stand and what to expect. LID - 10.3390\/medicina57060621 [doi] LID - 621","volume":"57","author":"Kardalas","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063288","article-title":"The role of fibrogenesis and extracellular matrix proteins in the pathogenesis of Graves' Ophthalmopathy","volume":"25","author":"Chiu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9622","DOI":"10.1038\/s41598-019-46075-1","article-title":"Macrophages promote a profibrotic phenotype in orbital fibroblasts through increased hyaluronic acid production and cell contractility","volume":"9","author":"Yang","year":"2019","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1475934","article-title":"The role of ferroptosis in neurodegenerative diseases","volume":"18","author":"Fei","year":"2024","journal-title":"Front Cell Neurosci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2510360","article-title":"Ferroptosis and its potential determinant role in myocardial susceptibility to ischemia\/reperfusion injury in diabetes","volume":"25","author":"Zhou","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41420-024-02037-9","article-title":"Ferroptosis: A double-edged sword","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death discov"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4161\/23723556.2014.995047","article-title":"Glutathione peroxidase 4 (Gpx4) and ferroptosis: what's so special about it","volume":"2","author":"Conrad","year":"2015","journal-title":"Mol Cell Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1440309","article-title":"Ferroptosis: a novel mechanism of cell death in ophthalmic conditions","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-021-00841-y","article-title":"Ferroptosis, radiotherapy, and combination therapeutic strategies","volume":"12","author":"Lei","year":"2021","journal-title":"Protein Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1068437","article-title":"Recent advances in ferroptosis and therapeutic strategies for glioblastoma","volume":"9","author":"Lu","year":"2022","journal-title":"Front Mol biosciences"},{"key":"B28","article-title":"Increased response to oxidative stress challenge in Graves' ophthalmopathy orbital fibroblasts","volume":"17","author":"Tsai","year":"2011","journal-title":"Mol Vis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4432584","article-title":"Therapeutic effect of gypenosides on antioxidant stress injury in orbital fibroblasts of Graves' Orbitopathy","volume":"2022","author":"Ma","year":"2022","journal-title":"J Immunol Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12929-022-00850-x","article-title":"The novel role of ER protein TXNDC5 in the pathogenesis of organ fibrosis: mechanistic insights and therapeutic implications","volume":"29","author":"Hung","year":"2022","journal-title":"J Biomed Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/jme-21-0057","article-title":"PERK mediates oxidative stress and adipogenesis in Graves' orbitopathy pathogenesis","volume":"66","author":"Ko","year":"2021","journal-title":"J Mol Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0948","article-title":"Histone deacetylase 4 controls extracellular matrix production in orbital fibroblasts from Graves' Ophthalmopathy patients","volume":"31","author":"Ekronarongchai","year":"2021","journal-title":"Thyroid"},{"key":"B33","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12967-023-04217-0","article-title":"RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse","volume":"21","author":"Chen","year":"2023","journal-title":"J Transl Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2023.11.040","article-title":"The biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death","volume":"84","author":"Ai","year":"2024","journal-title":"Mol Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.3390\/cells9122709","article-title":"Regulated necrotic cell death in alternative tumor therapeutic strategies","volume":"9","author":"Woo","year":"2020","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.10.011","article-title":"The metabolic underpinnings of ferroptosis","volume":"32","author":"Zheng","year":"2020","journal-title":"Cell Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP cyclohydrolase 1\/Tetrahydrobiopterin counteract ferroptosis through lipid remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent science"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e202105043","DOI":"10.1083\/jcb.202105043","article-title":"Mitochondrial regulation of ferroptosis","volume":"220","author":"Gan","year":"2021","journal-title":"J Cell Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/ars.2016.6698","article-title":"Heme-oxygenase I and PCG-1\u03b1 Regulate mitochondrial biogenesis via microglial activation of alpha7 nicotinic acetylcholine receptors using PNU282987","volume":"27","author":"Navarro","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205685","article-title":"Novel insights into the pathogenesis of thyroid eye disease through ferroptosis-related gene signature and immune infiltration analysis","volume":"16","author":"Ye","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"926","DOI":"10.21037\/atm-22-3470","article-title":"Mechanisms of immune-related differentially expressed genes in thyroid-associated ophthalmopathy based on the GEO database","volume":"10","author":"Gao","year":"2022","journal-title":"Ann Trans Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1118391","article-title":"Identification and validation of ferroptosis-related genes and immune cell infiltration in thyroid associated ophthalmopathy","volume":"14","author":"Chen","year":"2023","journal-title":"Front Genet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"bqaa088","DOI":"10.1210\/endocr\/bqaa088","article-title":"Polymorphisms of IRAK1 gene on X chromosome is associated with Hashimoto thyroiditis in Korean children","volume":"161","author":"Shin","year":"2020","journal-title":"Endocrinology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3390\/cells11121885","article-title":"Innate immune cell death in neuroinflammation and Alzheimer's disease","volume":"11","author":"Rajesh","year":"2022","journal-title":"Cells"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-023-2708-7","article-title":"Tea polyphenols reduce inflammation of orbital fibroblasts in Graves' Ophthalmopathy via the NF-\u03baB\/NLRP3 pathway","volume":"43","author":"Liu","year":"2023","journal-title":"Curr Med science"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.12659\/msm.917299","article-title":"Research on the potential mechanism of gypenosides on treating thyroid-associated ophthalmopathy based on network pharmacology","volume":"25","author":"Li","year":"2019","journal-title":"Med Sci Monit"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105607","article-title":"TMEM2 inhibits the development of Graves' orbitopathy through the JAK-STAT signaling pathway","volume":"300","author":"Li","year":"2024","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.65.2.25","article-title":"SOX9 induces orbital fibroblast activation in thyroid eye disease via MAPK\/ERK1\/2 pathway","volume":"65","author":"Zhou","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.9.24","article-title":"Transcriptomic profiling of control and thyroid-associated orbitopathy (TAO) orbital fat and TAO orbital fibroblasts undergoing adipogenesis","volume":"62","author":"Kim","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1257","article-title":"PI3K\/AKT pathway mediates induction of IL-1RA by TSH in fibrocytes: modulation by PTEN","volume":"99","author":"Li","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1087648","article-title":"Inflammation and histone modification in chronic pain","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101745","article-title":"Genotype-phenotype correlations in Graves' disease","volume":"37","author":"Radziszewski","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.881914","article-title":"Diagnostic and predictive values of ferroptosis-related genes in child sepsis","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.3390\/ijms20153683","article-title":"Arachidonic acid metabolism and kidney inflammation","volume":"20","author":"Wang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.1038\/s41467-021-27452-9","article-title":"A targetable LIFR-NF-\u03baB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis","volume":"12","author":"Yao","year":"2021","journal-title":"Nat Commun"},{"key":"B60","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","article-title":"Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis","volume":"10","author":"Tsurusaki","year":"2019","journal-title":"Cell Death Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107844","article-title":"Dimethyl fumarate improves cognitive deficits in chronic cerebral hypoperfusion rats by alleviating inflammation, oxidative stress, and ferroptosis via NRF2\/ARE\/NF-\u03baB signal pathway","volume":"98","author":"Yan","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0466-2","article-title":"Interferon target-gene expression and epigenomic signatures in health and disease","volume":"20","author":"Barrat","year":"2019","journal-title":"Nat Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.3ma1220-815rrr","article-title":"IFN\u03b3-mediated repression of system xc(-) drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells","volume":"110","author":"Kong","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16272","article-title":"Interferon-\u03b3 induces retinal pigment epithelial cell Ferroptosis by a JAK1-2\/STAT1\/SLC7A11 signaling pathway in Age-related Macular Degeneration","volume":"289","author":"Wei","year":"2022","journal-title":"FEBS J"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1294317","article-title":"Ferroptosis: an important player in the inflammatory response in diabetic nephropathy","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-10-23","article-title":"Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia","volume":"10","author":"Yao","year":"2013","journal-title":"J Neuroinflammation"},{"key":"B68","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41419-023-05930-w","article-title":"Ferroptosis as a potential target for cancer therapy","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113828","article-title":"Inhibition of TLR4 prevents hippocampal hypoxic-ischemic injury by regulating ferroptosis in neonatal rats","volume":"345","author":"Zhu","year":"2021","journal-title":"Exp Neurol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2022.129043","article-title":"The role of ferroptosis mediated by NRF2\/ERK-regulated ferritinophagy in CdTe QDs-induced inflammation in macrophage","volume":"436","author":"Liu","year":"2022","journal-title":"J Hazard Mater"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-10-3-366","article-title":"Connective tissue, glycosaminoglycans, and diseases of the thyroid","volume":"10","author":"Smith","year":"1989","journal-title":"Endocr Rev"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00167","article-title":"Building the case for insulin-like growth factor receptor-I involvement in thyroid-associated ophthalmopathy","volume":"7","author":"Smith","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J Exp Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.matbio.2015.05.005","article-title":"Latent TGF-\u03b2-binding proteins","volume":"47","author":"Robertson","year":"2015","journal-title":"Matrix Biol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2017.04.005","article-title":"Transforming growth factor-\u03b2 Receptors and smads: regulatory complexity and functional versatility","volume":"27","author":"Budi","year":"2017","journal-title":"Trends Cell Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2019.11.013","article-title":"Non-canonical (non-SMAD2\/3) TGF-\u03b2 signaling in fibrosis: Mechanisms and targets","volume":"101","author":"Finnson","year":"2020","journal-title":"Semin Cell Dev Biol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1210\/jc.2006-1824","article-title":"Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link","volume":"92","author":"Cawood","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1279","article-title":"Hypoxia-dependent HIF-1 activation impacts on tissue remodeling in Graves' Ophthalmopathy-implications for smoking","volume":"101","author":"G\u00f6rtz","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4676289","article-title":"Cigarette smoke extract-induced oxidative stress and fibrosis-related genes expression in orbital fibroblasts from patients with Graves' Ophthalmopathy","volume":"2016","author":"Kau","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-310723","article-title":"Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy","volume":"102","author":"Jang","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.12659\/msm.890686","article-title":"Increased microRNA-155 and decreased microRNA-146a may promote ocular inflammation and proliferation in Graves' ophthalmopathy","volume":"20","author":"Li","year":"2014","journal-title":"Med Sci Monit"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.19-27865","article-title":"TSHR Signaling Stimulates Proliferation Through PI3K\/Akt and Induction of miR-146a and miR-155 in Thyroid Eye Disease Orbital Fibroblasts","volume":"60","author":"Woeller","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.12.007","article-title":"Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm Sinica B"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2019.1687985","article-title":"RNA-binding protein ZFP36\/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells","volume":"16","author":"Zhang","year":"2020","journal-title":"Autophagy"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002907","article-title":"Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102509","article-title":"Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model","volume":"57","author":"Pei","year":"2022","journal-title":"Redox Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e382523","DOI":"10.1590\/acb382523","article-title":"Puerarin alleviated oxidative stress and ferroptosis during renal fibrosis induced by ischemia\/reperfusion injury via TLR4\/Nox4 pathway in rats","volume":"38","author":"Jian","year":"2023","journal-title":"Acta Cir Bras"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01663-9","article-title":"2021 update on thyroid-associated ophthalmopathy","volume":"45","author":"Neag","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05377-9","article-title":"Age-related difference in extraocular muscles and its relation to clinical manifestations in an ethnically homogenous group of patients with Graves' orbitopathy","volume":"260","author":"Su","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.6b01632","article-title":"Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy","volume":"16","author":"Luo","year":"2016","journal-title":"Nano Lett"},{"key":"B91","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-022-01297-1","article-title":"Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis","volume":"15","author":"Xie","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0671","article-title":"Immunophenotype of lacrimal glands in Graves Orbitopathy: implications for the pathogenesis of Th1 and Th17 immunity","volume":"32","author":"Huang","year":"2022","journal-title":"Thyroid"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.7.27","article-title":"Ferroptosis in the lacrimal gland is involved in dry eye syndrome induced by corneal nerve severing","volume":"64","author":"Liu","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B94","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12935-022-02685-w","article-title":"The role of ferroptosis in esophageal cancer","volume":"22","author":"Wang","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2019.92803","article-title":"Etanercept in the treatment of Graves' ophthalmopathy with primary hypothyroidism and rheumatoid arthritis","volume":"44","author":"Boskovic","year":"2019","journal-title":"Cent Eur J Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109515","article-title":"Lutein targeting orbital fibroblasts attenuates fibrotic and inflammatory effects in thyroid-associated ophthalmopathy","volume":"232","author":"Hei","year":"2023","journal-title":"Exp Eye Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.7b00028","article-title":"On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death","volume":"3","author":"Zilka","year":"2017","journal-title":"ACS Cent science"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1021\/ja411006a","article-title":"Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models","volume":"136","author":"Skouta","year":"2014","journal-title":"J Am Chem Soc"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109347","article-title":"Ferrostatin-1 attenuates pathological angiogenesis in oxygen-induced retinopathy via inhibition of ferroptosis","volume":"226","author":"Liu","year":"2023","journal-title":"Exp Eye Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s13063-023-07282-4","article-title":"Efficacy of selenium supplementation for mild-to-moderate Graves' ophthalmopathy in a selenium-sufficient area (SeGOSS trial): study protocol for a phase III, multicenter, open-label, randomized, controlled intervention trial","volume":"24","author":"Chung","year":"2023","journal-title":"Trials"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2020.03.012","article-title":"Selenium: tracing another essential element of ferroptotic cell death","volume":"27","author":"Conrad","year":"2020","journal-title":"Cell Chem Biol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3892\/etm.2023.12067","article-title":"Ferroptosis: A potential therapeutic target in autoimmune disease (Review)","volume":"26","author":"Shen","year":"2023","journal-title":"Exp Ther Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1210\/clinem\/dgac163","article-title":"Insights into ferroptosis: targeting glycolysis to treat Graves' Orbitopathy","volume":"107","author":"Ma","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B104","article-title":"SIRT6 drives sensitivity to ferroptosis in anaplastic thyroid cancer through NCOA4-dependent autophagy","volume":"13","author":"Yang","year":"2023","journal-title":"Am J Cancer Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23136879","article-title":"Ferroptosis modulation: potential therapeutic target for glioblastoma treatment. LID - 10.3390\/ijms23136879 [doi] LID - 6879","volume":"23","author":"de Souza","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B106","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1210\/endrev\/bnad016","article-title":"Treating the side effects of exogenous glucocorticoids; can we separate the good from the bad","volume":"44","author":"Pofi","year":"2023","journal-title":"Endocr Rev"},{"key":"B107","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal transduction targeted Ther"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0389","article-title":"Will biological agents supplant systemic glucocorticoids as the first-line treatment for thyroid-associated ophthalmopathy","volume":"181","author":"Smith","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1038225","article-title":"Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer","volume":"13","author":"Qi","year":"2022","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41420-021-00579-w","article-title":"Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases","volume":"7","author":"Yu","year":"2021","journal-title":"Cell Death discov"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.844757","article-title":"Molecular mechanisms of iron mediated programmed cell death and its roles in eye diseases","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Nutr"},{"key":"B112","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s43556-023-00142-2","article-title":"The mechanism of ferroptosis and its related diseases","volume":"4","author":"Feng","year":"2023","journal-title":"Mol biomed"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116230","article-title":"Natural compounds efficacy in Ophthalmic Diseases: A new twist impacting ferroptosis","volume":"172","author":"Yuan","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1112751","article-title":"Current insights into the functional roles of ferroptosis in musculoskeletal diseases and therapeutic implications","volume":"11","author":"Zhang","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/antiox10060986","article-title":"Opportunities for ferroptosis in cancer therapy","volume":"10","author":"Fujihara","year":"2021","journal-title":"Antioxidants (Basel Switzerland)"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S448715","article-title":"Advances in ferroptosis-inducing agents by targeted delivery system in cancer therapy","volume":"19","author":"Xiang","year":"2024","journal-title":"Int J nanomed"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100785","article-title":"Redox modulation and induction of ferroptosis as a new therapeutic strategy in hepatocellular carcinoma","volume":"13","author":"Lippmann","year":"2020","journal-title":"Transl Oncol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1684\/abc.2024.1866","article-title":"Programmed cell death in autoimmune diseases: ferroptosis","volume":"82","author":"Sun","year":"2024","journal-title":"Ann Biol Clin (Paris)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1475923\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T05:10:21Z","timestamp":1733461821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1475923\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":118,"alternative-id":["10.3389\/fimmu.2024.1475923"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1475923","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"article-number":"1475923"}}